Bladder Cancer Incidence and Mortality by Year, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 3,289 20.0 19.3-20.7 2,389 36.2 34.7-37.8 900 9.3 8.7-9.9 1,029 6.7 6.3-7.1 719 12.1 11.2-13.1 310 3.4 3.0-3.8
1977 3,402 20.5 19.8-21.3 2,442 36.5 35.0-38.0 960 10.0 9.4-10.7 1,037 6.7 6.3-7.1 718 12.1 11.2-13.0 319 3.4 3.0-3.8
1978 3,578 21.6 20.9-22.3 2,590 39.1 37.5-40.7 988 10.2 9.5-10.8 1,012 6.4 6.0-6.8 690 11.5 10.6-12.4 322 3.4 3.0-3.8
1979 3,620 21.6 20.9-22.4 2,625 39.6 38.0-41.2 995 10.1 9.4-10.7 1,006 6.4 6.0-6.8 674 11.2 10.3-12.1 332 3.5 3.1-3.9
1980 3,809 22.5 21.7-23.2 2,805 41.6 40.0-43.2 1,004 10.0 9.4-10.7 985 6.0 5.7-6.4 681 11.1 10.3-12.0 304 3.1 2.7-3.5
1981 3,695 21.7 21.0-22.4 2,698 39.9 38.3-41.5 997 9.9 9.3-10.6 996 6.1 5.7-6.5 686 11.3 10.4-12.2 310 3.1 2.8-3.5
1982 3,773 21.9 21.2-22.6 2,703 39.5 37.9-41.0 1,070 10.5 9.9-11.2 962 5.8 5.4-6.2 664 10.7 9.9-11.6 298 2.9 2.6-3.3
1983 3,844 22.2 21.5-22.9 2,780 40.9 39.4-42.6 1,064 10.3 9.7-10.9 922 5.5 5.2-5.9 635 10.5 9.7-11.4 287 2.8 2.5-3.1
1984 3,730 21.3 20.6-22.0 2,689 38.6 37.1-40.2 1,041 10.1 9.5-10.7 935 5.6 5.3-6.0 630 10.3 9.4-11.1 305 2.9 2.6-3.3
1985 3,746 21.4 20.7-22.1 2,681 38.6 37.1-40.2 1,065 10.3 9.6-10.9 939 5.6 5.2-5.9 634 10.3 9.4-11.1 305 2.9 2.6-3.3
1986 3,891 22.1 21.4-22.8 2,817 40.3 38.8-41.9 1,074 10.3 9.7-11.0 914 5.4 5.1-5.8 610 10.1 9.2-10.9 304 2.9 2.5-3.2
1987 3,752 21.1 20.4-21.8 2,680 37.9 36.4-39.4 1,072 10.1 9.5-10.8 859 5.0 4.7-5.4 575 9.2 8.4-10.0 284 2.7 2.4-3.0
1988 3,748 21.0 20.3-21.7 2,669 37.6 36.1-39.1 1,079 10.2 9.6-10.8 919 5.3 4.9-5.6 596 9.2 8.5-10.0 323 3.0 2.7-3.3
1989 3,733 20.9 20.2-21.6 2,686 38.0 36.5-39.5 1,047 9.8 9.2-10.5 906 5.2 4.9-5.6 618 9.8 9.0-10.6 288 2.6 2.3-3.0
1990 3,865 21.6 20.9-22.3 2,739 38.6 37.1-40.1 1,126 10.6 10.0-11.2 890 5.1 4.8-5.5 574 9.0 8.3-9.8 316 2.9 2.6-3.2
1991 3,901 21.6 20.9-22.3 2,797 39.0 37.5-40.5 1,104 10.3 9.7-11.0 857 4.8 4.5-5.2 580 8.9 8.2-9.7 277 2.5 2.2-2.8
1992 3,918 21.6 20.9-22.3 2,773 38.6 37.1-40.1 1,145 10.7 10.1-11.3 885 4.9 4.6-5.3 542 8.4 7.7-9.1 343 3.1 2.7-3.4
1993 3,992 21.8 21.1-22.5 2,786 38.0 36.6-39.5 1,206 11.1 10.5-11.8 940 5.2 4.9-5.6 626 9.5 8.8-10.3 314 2.8 2.5-3.1
1994 3,964 21.6 20.9-22.3 2,795 38.1 36.6-39.6 1,169 10.8 10.2-11.4 918 5.0 4.7-5.4 603 9.1 8.3-9.8 315 2.8 2.5-3.1
1995 4,068 22.0 21.4-22.7 2,868 38.8 37.4-40.3 1,200 11.0 10.4-11.6 912 5.0 4.7-5.3 588 8.7 8.0-9.4 324 2.8 2.5-3.2
1996 4,163 22.4 21.8-23.1 3,007 40.4 38.9-41.9 1,156 10.5 9.9-11.2 932 5.0 4.7-5.4 604 8.9 8.2-9.7 328 2.8 2.5-3.2
1997 4,471 23.9 23.2-24.6 3,185 42.1 40.6-43.6 1,286 11.6 11.0-12.3 942 5.0 4.7-5.4 617 8.9 8.2-9.6 325 2.8 2.5-3.1
1998 4,630 24.5 23.8-25.2 3,316 43.2 41.7-44.7 1,314 11.8 11.2-12.5 929 4.9 4.6-5.2 620 8.8 8.1-9.5 309 2.6 2.3-2.9
1999 4,561 23.8 23.1-24.5 3,264 41.9 40.5-43.4 1,297 11.5 10.9-12.2 913 4.7 4.4-5.1 619 8.7 8.0-9.4 294 2.5 2.2-2.8
2000 4,673 24.1 23.4-24.8 3,332 42.2 40.8-43.7 1,341 11.7 11.1-12.3 925 4.7 4.4-5.0 621 8.4 7.7-9.1 304 2.5 2.2-2.8
2001 4,625 23.6 22.9-24.3 3,345 42.0 40.6-43.5 1,280 11.1 10.5-11.7 946 4.8 4.5-5.1 644 8.7 8.0-9.4 302 2.4 2.2-2.7
2002 4,729 23.8 23.2-24.5 3,463 42.8 41.4-44.3 1,266 10.9 10.3-11.5 904 4.5 4.2-4.8 588 7.8 7.2-8.5 316 2.6 2.3-2.9
2003 4,879 24.4 23.7-25.1 3,568 43.3 41.9-44.7 1,311 11.2 10.6-11.8 847 4.2 3.9-4.5 567 7.4 6.8-8.1 280 2.2 2.0-2.5
2004 5,035 24.9 24.2-25.6 3,668 44.0 42.6-45.5 1,367 11.5 10.9-12.2 922 4.5 4.2-4.8 624 7.9 7.3-8.5 298 2.4 2.1-2.7
2005 5,082 24.9 24.2-25.6 3,680 43.7 42.3-45.1 1,402 11.7 11.1-12.4 888 4.3 4.0-4.6 582 7.4 6.8-8.0 306 2.4 2.1-2.7
2006 4,983 24.2 23.6-24.9 3,677 43.4 42.0-44.8 1,306 11.0 10.4-11.6 891 4.3 4.0-4.6 599 7.5 6.9-8.1 292 2.3 2.0-2.6
2007 5,010 24.1 23.5-24.8 3,665 42.5 41.1-43.9 1,345 11.3 10.7-11.9 981 4.6 4.3-4.9 671 8.2 7.6-8.8 310 2.4 2.1-2.7
2008 5,172 24.5 23.8-25.2 3,883 44.2 42.8-45.6 1,289 10.6 10.0-11.2 957 4.5 4.2-4.8 654 7.9 7.3-8.5 303 2.3 2.1-2.6
2009 5,199 24.3 23.7-25.0 3,837 43.0 41.7-44.4 1,362 11.0 10.4-11.6 953 4.4 4.1-4.7 684 8.1 7.5-8.7 269 2.0 1.8-2.3
2010 4,917 22.6 22.0-23.3 3,698 40.7 39.4-42.1 1,219 9.7 9.2-10.3 1,015 4.6 4.3-4.9 693 7.9 7.3-8.5 322 2.4 2.1-2.7
2011 5,285 24.0 23.3-24.7 3,923 42.2 40.9-43.6 1,362 10.9 10.3-11.5 956 4.2 4.0-4.5 653 7.4 6.8-8.0 303 2.2 2.0-2.5
2012 5,366 23.8 23.2-24.5 3,939 41.8 40.5-43.1 1,427 10.9 10.4-11.5 989 4.3 4.0-4.6 674 7.4 6.8-8.0 315 2.3 2.0-2.5
2013 5,458 24.0 23.3-24.6 4,043 42.1 40.8-43.4 1,415 10.8 10.3-11.4 978 4.2 3.9-4.5 692 7.5 6.9-8.1 286 2.0 1.8-2.2
2014 5,358 23.0 22.3-23.6 3,974 40.2 38.9-41.5 1,384 10.3 9.8-10.9 1,058 4.4 4.2-4.7 717 7.6 7.1-8.2 341 2.4 2.1-2.6
2015 5,398 22.8 22.2-23.4 4,032 39.9 38.7-41.2 1,366 10.2 9.7-10.8 986 4.1 3.8-4.3 667 6.8 6.3-7.4 319 2.2 2.0-2.5
2016 5,452 22.5 21.9-23.2 4,096 39.6 38.4-40.9 1,356 9.8 9.3-10.4 1,010 4.1 3.9-4.4 708 7.2 6.7-7.8 302 2.1 1.8-2.3
2017 5,525 22.5 21.9-23.1 4,112 39.1 37.9-40.4 1,413 10.1 9.6-10.7 986 3.9 3.7-4.2 684 6.8 6.3-7.3 302 2.0 1.8-2.3
2018 5,427 21.6 21.1-22.2 4,045 37.4 36.3-38.6 1,382 9.8 9.3-10.3 987 3.9 3.6-4.1 690 6.7 6.2-7.2 297 2.0 1.8-2.2
2019 5,503 21.7 21.1-22.3 4,075 37.0 35.9-38.2 1,428 10.0 9.5-10.5 930 3.6 3.3-3.8 666 6.3 5.8-6.8 264 1.7 1.5-1.9
2020 4,905 19.0 18.5-19.5 3,677 32.8 31.7-33.9 1,228 8.5 8.0-9.0 878 3.3 3.1-3.6 613 5.8 5.3-6.2 265 1.7 1.5-1.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.